Impax Files Motion to Intervene as Defendant in Suit Related to Generic Allegra-D

Impax Laboratories Inc. has filed a motion in the U.S. District Court for the District of Columbia to intervene as a defendant in a lawsuit by Barr Laboratories, Inc. against the FDA. Earlier this month, Barr Laboratories, a subsidiary of Barr Pharmaceuticals Inc. brought suit against the FDA in an attempt to prevent the agency from granting final approval to Impax's abbreviated new drug application (ANDA) for its fexofenadine HCl and pseudoephedrine HCl extended-release tablets, a generic version of Allegra-D.

Yahoo News (http://biz.yahoo.com/bw/050228/285427_1.html)